BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31136095)

  • 21. Rheumatoid factor, complement, and mixed cryoglobulinemia.
    Gorevic PD
    Clin Dev Immunol; 2012; 2012():439018. PubMed ID: 22956968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
    Brito-Zerón P; Gheitasi H; Retamozo S; Bové A; Londoño M; Sánchez-Tapias JM; Caballero M; Kostov B; Forns X; Kaveri SV; Ramos-Casals M
    Arthritis Res Ther; 2015 Sep; 17(1):250. PubMed ID: 26370711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
    Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients.
    Weiner SM; Thiel J; Berg T; Weber S; Krumme B; Peter HH; Rump LC; Grotz WH
    Clin Transplant; 2004 Feb; 18(1):7-13. PubMed ID: 15108765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease.
    Wei G; Yano S; Kuroiwa T; Hiromura K; Maezawa A
    Clin Exp Immunol; 1997 Jan; 107(1):83-8. PubMed ID: 9010261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of auto-antiidiotypic activity between the IgM and IgG fractions of human mixed cryoglobulins.
    Stone GC; Nardella FA; Oppliger IR; Mannik M
    J Immunol; 1988 May; 140(9):3114-9. PubMed ID: 3129510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral ischemic attack secondary to hepatitis C virus infection.
    Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
    Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients.
    Faguer S; Kamar N; Boulestin A; Esposito L; Durand D; Blancher A; Rostaing L
    Clin Nephrol; 2008 Apr; 69(4):239-43. PubMed ID: 18397697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.
    Lee KC; Cheng YT; Lin CY; Kuo CJ; Chien RN; Yeh CT; Chang ML
    Eur J Clin Invest; 2020 Jan; 50(1):e13189. PubMed ID: 31782138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryoglobulins: An update on detection, mechanisms and clinical contribution.
    Kolopp-Sarda MN; Miossec P
    Autoimmun Rev; 2018 May; 17(5):457-464. PubMed ID: 29526627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclasses of Monoclonal (Type I) Immunoglobulin G Cryoglobulins: Report on Two Distinct Cases with Myeloma.
    Petersen T; Riviere S; Malbos S; Chantran Y; Abbas A; Chasset F; Mekinian A; Sellam J; Garderet L; Aucouturier P
    Clin Lab; 2018 Apr; 64(4):615-618. PubMed ID: 29739081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of complement-fixing activity and cross-idiotypes of rheumatoid factors in idiopathic mixed cryoglobulinemia.
    Powell R; Agnello V
    Clin Immunol Immunopathol; 1983 Oct; 29(1):146-51. PubMed ID: 6411403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia.
    Pietrogrande M; Corona M; Milani S; Rosti A; Ramella M; Tordato G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S109-13. PubMed ID: 8730489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rheumatoid factor and cryoglobulin are not efficiently related to cold activation of complement].
    Nakagawa T; Ueda K; Nakajima H; Shimizu A
    Rinsho Byori; 1995 Jan; 43(1):21-5. PubMed ID: 7884960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibody activity of cryoglobulins and sera in systemic lupus erythematosus. Association of IgM class rheumatoid factors with Raynaud's syndrome.
    Gripenberg M; Teppo AM; Kurki P; Gripenberg G; Helve T
    Scand J Rheumatol; 1988; 17(4):249-54. PubMed ID: 3263699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics and outcome of patients with type Ⅱ cryoglobulinemia].
    Han HX; Cao XX; Su W; Shen KN; Zhang L; Zhou DB; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):447-451. PubMed ID: 34384149
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of IgM rheumatoid factor in experimental immune vasculitis.
    Floyd M; Tesar JT
    Clin Exp Immunol; 1979 Apr; 36(1):165-74. PubMed ID: 157238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.